EBITDA margin improved by 176 bps YoY to 24.2% despite soft Revlimid sales, mainly driven by an improvement in the mix. The net profit grew by 9.9% YoY to Rs8bn mainly on the back of a strong operational performance, which was partially offset by a higher tax rate on account of DTA reversal.
SIFs gain investor traction with over Rs 38,000 crore in assets. Should investors add them to their portfolios this Diwali?
India’s Specialised Investment Funds (SIFs) crossed Rs 38,000 crore in assets in September 2026, offering flexible long-short and derivatives-based strategies. While experts see growth potential,